YourChoice
8 known investors
Find your way into YourChoice
YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials. The company targets male contraceptive users seeking alternatives to condoms or vasectomy.
Founders & leadership
AB
Akash Bakshi, MScCo-founder & CEO
NM
Nadja Mannowetz, PhDCo-founder & CSO
Investors · 8
Competitors · 3
by search overlapRead on Scientific American31 shared keywordsScientific American is a media organization that publishes research and ideas across science, health, technology and society through multiple formats including print, web, video, and podcasts. Founded in 1845, it reaches over 20 million people monthly and maintains editorial independence while providing trustworthy science communication and commentary.
Medscape25 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Inverse20 shared keywordsInverse is an online media publication covering entertainment, science fiction, film, television, and pop culture, including reviews, interviews, and news about movies and comic-based franchises. It publishes editorial articles and a daily newsletter for a general audience of genre and entertainment fans.
Companies competing with YourChoice for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does YourChoice do?
- YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials. The company targets male contraceptive users seeking alternatives to condoms or vasectomy.
- Who founded YourChoice?
- YourChoice was founded by Akash Bakshi, MSc, Nadja Mannowetz, PhD.
- Who are YourChoice's investors?
- YourChoice's investors include Blue Bear Ventures, Civilization Ventures Management, Llc, Foreground Capital, Future Ventures, North South Ventures, Portfolia, Olive Tree Capital, Refactor Capital.